| pubmed-article:7215442 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:7215442 | lifeskim:mentions | umls-concept:C0034798 | lld:lifeskim |
| pubmed-article:7215442 | lifeskim:mentions | umls-concept:C0221198 | lld:lifeskim |
| pubmed-article:7215442 | lifeskim:mentions | umls-concept:C0005456 | lld:lifeskim |
| pubmed-article:7215442 | lifeskim:mentions | umls-concept:C0205812 | lld:lifeskim |
| pubmed-article:7215442 | lifeskim:mentions | umls-concept:C0599278 | lld:lifeskim |
| pubmed-article:7215442 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:7215442 | pubmed:dateCreated | 1981-6-23 | lld:pubmed |
| pubmed-article:7215442 | pubmed:abstractText | Kainic acid lesion of rat striata reduces the specific dopamine receptor binding of the butyrophenone antagonist [3H]spiperone and the butyrophenone-like antagonist [3H]domperidone by 56% and 59% respectively. Significantly greater decreases in binding were observed with the agonist [3H]N-propylnorapomorphine (NPA) and the antagonist [3H]flupentixol which showed 79% and 73% losses of high affinity binding respectively. These data indicate that, in part, [3H]spiperone and [3H]domperidone label distinct dopamine receptors with different neuronal localizations from those labeled by [3H]flupentixol and [3H]NPA. Our data is consistent with the hypothesis that [3H]flupentixol and [3H]NPA bind preferentially to adenylate cyclase-linked dopamine (D1) receptors. | lld:pubmed |
| pubmed-article:7215442 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7215442 | pubmed:language | eng | lld:pubmed |
| pubmed-article:7215442 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7215442 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:7215442 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7215442 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7215442 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7215442 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7215442 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7215442 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7215442 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7215442 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7215442 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7215442 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7215442 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:7215442 | pubmed:month | Mar | lld:pubmed |
| pubmed-article:7215442 | pubmed:issn | 0014-2999 | lld:pubmed |
| pubmed-article:7215442 | pubmed:author | pubmed-author:AdamsLL | lld:pubmed |
| pubmed-article:7215442 | pubmed:author | pubmed-author:CreeseII | lld:pubmed |
| pubmed-article:7215442 | pubmed:author | pubmed-author:HyttelJJ | lld:pubmed |
| pubmed-article:7215442 | pubmed:author | pubmed-author:LeffSS | lld:pubmed |
| pubmed-article:7215442 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:7215442 | pubmed:day | 5 | lld:pubmed |
| pubmed-article:7215442 | pubmed:volume | 70 | lld:pubmed |
| pubmed-article:7215442 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:7215442 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:7215442 | pubmed:pagination | 71-5 | lld:pubmed |
| pubmed-article:7215442 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
| pubmed-article:7215442 | pubmed:meshHeading | pubmed-meshheading:7215442-... | lld:pubmed |
| pubmed-article:7215442 | pubmed:meshHeading | pubmed-meshheading:7215442-... | lld:pubmed |
| pubmed-article:7215442 | pubmed:meshHeading | pubmed-meshheading:7215442-... | lld:pubmed |
| pubmed-article:7215442 | pubmed:meshHeading | pubmed-meshheading:7215442-... | lld:pubmed |
| pubmed-article:7215442 | pubmed:meshHeading | pubmed-meshheading:7215442-... | lld:pubmed |
| pubmed-article:7215442 | pubmed:meshHeading | pubmed-meshheading:7215442-... | lld:pubmed |
| pubmed-article:7215442 | pubmed:meshHeading | pubmed-meshheading:7215442-... | lld:pubmed |
| pubmed-article:7215442 | pubmed:meshHeading | pubmed-meshheading:7215442-... | lld:pubmed |
| pubmed-article:7215442 | pubmed:meshHeading | pubmed-meshheading:7215442-... | lld:pubmed |
| pubmed-article:7215442 | pubmed:meshHeading | pubmed-meshheading:7215442-... | lld:pubmed |
| pubmed-article:7215442 | pubmed:meshHeading | pubmed-meshheading:7215442-... | lld:pubmed |
| pubmed-article:7215442 | pubmed:meshHeading | pubmed-meshheading:7215442-... | lld:pubmed |
| pubmed-article:7215442 | pubmed:meshHeading | pubmed-meshheading:7215442-... | lld:pubmed |
| pubmed-article:7215442 | pubmed:meshHeading | pubmed-meshheading:7215442-... | lld:pubmed |
| pubmed-article:7215442 | pubmed:year | 1981 | lld:pubmed |
| pubmed-article:7215442 | pubmed:articleTitle | Kainate lesion dissociates striatal dopamine receptor radioligand binding sites. | lld:pubmed |
| pubmed-article:7215442 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:7215442 | pubmed:publicationType | In Vitro | lld:pubmed |
| pubmed-article:7215442 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7215442 | lld:pubmed |
